LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)

US5393193017 - Common Stock

2.4  +0.07 (+3%)

After market: 2.32 -0.08 (-3.33%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
YoY % growth
200KN/A
-100.00%		N/AN/AN/AN/AN/AN/AN/A
EBITDA
YoY % growth
-2.4MN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-2.4M-2.65M
-10.42%		N/A
19.62%		N/A
15.02%		N/A
-18.23%		N/A
-16.36%		N/A
-31.33%		N/A
-105.50%		N/A
6.10%		N/A
19.33%
Operating Margin
N/A-1,325.00%N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A